Pembrolizumab vs chemotherapy for MSI-high/dMMR metastatic colorectal cancer: Asia subgroup of phase 3 KEYNOTE-177 Meeting Abstract
| Authors: | Yoshino, T.; Kim, T. W.; Yong, W. P.; Shiu, K. K.; Jensen, B. V.; Jensen, L. H.; Smith, D.; Garcia-Carbonero, R.; Alcaide-Garcia, J.; Gibbs, P.; de la Fouchardiere, C.; Rivera, F.; Elez, E.; Bendell, J.; Le, D. T.; Yang, P.; Farooqui, M.; Marinello, P.; Diaz, L. A. Jr; Andre, T. |
| Abstract Title: | Pembrolizumab vs chemotherapy for MSI-high/dMMR metastatic colorectal cancer: Asia subgroup of phase 3 KEYNOTE-177 |
| Meeting Title: | 2021 Annual Meeting of the Japanese Society of Medical Oncology (JSMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2021 Feb 18-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-07-01 |
| Start Page: | S284 |
| Language: | English |
| ACCESSION: | WOS:000683609100106 |
| DOI: | 10.1016/j.annonc.2021.05.518 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: PS1-2 -- Source: Wos |
